Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities
Open Access
- 22 January 2022
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 116, 328-330
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention (164.506)
This publication has 9 references indexed in Scilit:
- Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysisThe American Journal of Emergency Medicine, 2021
- Disability and COVID-19: ensuring no one is left behindArchives of Public Health, 2021
- Brief Report: Impact of COVID-19 in Individuals with Autism Spectrum Disorders: Analysis of a National Private Claims Insurance DatabaseJournal of Autism and Developmental Disorders, 2021
- Health Risks and Consequences of a COVID-19 Infection for People with Disabilities: Scoping Review and Descriptive Thematic AnalysisInternational Journal of Environmental Research and Public Health, 2021
- COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million AdultsAnnals of Internal Medicine, 2021
- COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive studyBJPsych Open, 2020
- Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysisDisability and Health Journal, 2020
- Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative DataMedical Care, 2017
- Systematic Review of Comorbidity Indices for Administrative DataMedical Care, 2012